07 March 2019 : Animal Research
(–)-Epigallocatechin-3-Gallate Protects Against Lithium-Pilocarpine-Induced Epilepsy by Inhibiting the Toll-Like Receptor 4 (TLR4)/Nuclear Factor-κB (NF-κB) Signaling Pathway
DOI: 10.12659/MSM.915025
Med Sci Monit 2019; 25:1749-1758
HTML version available soon